Stocksigma LogoStocksigma Logo

CORONA Remedies Secures ANVISA GMP Certification for Bhayla Facility

CORONA Remedies received Good Manufacturing Practice (GMP) certification from Brazil's ANVISA on 22nd Oct'26 for its Bhayla, Ahmedabad facility, covering

CORONA Remedies Secures ANVISA GMP Certification for Bhayla Facility

Corona Remedies Ltd 路 Press Release 路 23 Oct 2026, 12:12 am

CORONA Remedies Secures ANVISA GMP Certification for Bhayla Facility CORONA Remedies received Good Manufacturing Practice (GMP) certification from Brazil's ANVISA on 22nd Oct'26 for its Bhayla, Ahmedabad facility, covering Oral Solid Dosage and Women's Hormone production lines. This marks the company's third major global GMP clearance, complementing existing EU-GMP and EAEU-GMP accreditations. While India remains its core market driving over 96% of revenue, the approval facilitates strategic expansion into Brazil's estimated USD 44 billion pharmaceutical market.

Original exchange filing (PDF)

More announcements from Corona Remedies Ltd

All Corona Remedies Ltd announcements